Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

BioAge Labs (BIOA) EBIT Margin (2025)

BioAge Labs (BIOA) has disclosed EBIT Margin for 1 consecutive years, with 923.42% as the latest value for Q4 2025.

  • Quarterly EBIT Margin changed N/A to 923.42% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1031.46% through Dec 2025, changed N/A year-over-year, with the annual reading at 1031.46% for FY2025, N/A changed from the prior year.
  • EBIT Margin hit 923.42% in Q4 2025 for BioAge Labs, up from 1126.58% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 923.42% in Q4 2025 to a low of 1133.43% in Q1 2025.